Use of progesterone as a preventive medicine and nifedipine as a treatment of preterm labor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yun-Sook | - |
dc.date.accessioned | 2021-08-11T12:43:34Z | - |
dc.date.available | 2021-08-11T12:43:34Z | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.issn | 2093-5951 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6171 | - |
dc.description.abstract | Preterm birth is a major cause of neonatal morbidity and mortality, and occurs in 5% to 15% of all pregnancies. Therefore, its prevention is a major opportunity to reduce medical costs and to promote public health in all countries. Preterm birth is a broad great obstetric syndrome that arises from a wide variety of causes. Although many therapeutic agents are used for premature labor, most of them have serious maternal side effects, and they are ineffective in cases when labor has already begun. Therefore, the authors would like to introduce progesterone, as a treatment to prevent preterm labor. We also investigated whether nifedipine, which is used to treat preterm labor, could prevent preterm labor. We are eager to find more effective and easier-to-use drugs to prevent preterm labor in the future. | - |
dc.format.extent | 5 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한의사협회 | - |
dc.title | Use of progesterone as a preventive medicine and nifedipine as a treatment of preterm labor | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5124/jkma.2018.61.3.214 | - |
dc.identifier.scopusid | 2-s2.0-85044506827 | - |
dc.identifier.wosid | 000428870400010 | - |
dc.identifier.bibliographicCitation | 대한의사협회지, v.61, no.3, pp 214 - 218 | - |
dc.citation.title | 대한의사협회지 | - |
dc.citation.volume | 61 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 214 | - |
dc.citation.endPage | 218 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002324936 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | 17-ALPHA-HYDROXYPROGESTERONE CAPROATE | - |
dc.subject.keywordPlus | MEDROXYPROGESTERONE ACETATE | - |
dc.subject.keywordPlus | MAGNESIUM-SULFATE | - |
dc.subject.keywordPlus | PREMATURE LABOR | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | BIRTH | - |
dc.subject.keywordPlus | PREGNANCY | - |
dc.subject.keywordPlus | RITODRINE | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordAuthor | Obstetric labor | - |
dc.subject.keywordAuthor | premature | - |
dc.subject.keywordAuthor | Progesterone | - |
dc.subject.keywordAuthor | Nifedipine | - |
dc.subject.keywordAuthor | Prevention & control | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.